CARSON CITY, Nev. (KOLO)-- Nevada will receive $1.86 million from Johnson & Johnson and Ethicon, Inc., a subsidiary, to settle allegations it deceptively marketed mesh devices for women.
Johnson & Johnson sold transvaginal surgical mesh devices that were surgically implanted in women to help them with bladder issues or to help them when organs shift from their original positions.
The total settlement is for $116.9 million for Nevada, 40 other states and the District of Columbia. Other states, including California, have their own litigation pending.
In announcing the settlement Thursday, Nevada Attorney General Aaron Ford said Johnson & Johnson misrepresented the safety and effectiveness of the devices and failed to sufficiently disclose the risks of using them, including chronic pain and inflammation, mesh erosion through the vagina, incontinence developing after surgery, painful sexual relations and vaginal scarring.
“When companies’ actions risk the safety of Nevadans, my office works to hold them accountable,” Ford said in a statement. “Medical device companies should fully disclose the safety, effectiveness and risks associated with their products so Nevadans can make informed decisions about their medical care.”
J&J said that the settlement doesn't include admission of any misconduct, The Associated Press reported.
The settlement comes as J&J is swamped with thousands of lawsuits claiming patients were harmed by products including baby powder, opioid painkillers and prescription drugs.
Earlier this year the Food and Drug Administration stopped the sale of transvaginal surgical mesh.
Copyright KOLO-TV 2019